Published in Cancer Discov on June 11, 2014
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med (2014) 6.89
Mutations driving CLL and their evolution in progression and relapse. Nature (2015) 2.06
Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. Blood (2015) 1.70
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia. J Exp Med (2015) 1.57
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations. Blood (2015) 1.56
MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance. Blood (2015) 1.52
Metabolic gatekeeper function of B-lymphoid transcription factors. Nature (2017) 1.40
DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nat Genet (2016) 1.06
Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia. Oncotarget (2015) 1.03
Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution. Haematologica (2015) 0.91
Clonal hematopoiesis in acquired aplastic anemia. Blood (2016) 0.89
Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia. Blood (2015) 0.89
The molecular pathogenesis of chronic lymphocytic leukaemia. Nat Rev Cancer (2016) 0.86
Myelodysplastic Syndromes Diagnosis: What Is the Role of Molecular Testing? Curr Hematol Malig Rep (2015) 0.85
Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia Cells. PLoS One (2015) 0.82
Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors. Haematologica (2016) 0.81
Human memory B cells. Leukemia (2016) 0.77
A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia. Clin Cancer Res (2016) 0.77
Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia. Leukemia (2016) 0.77
Unexpected functions of nuclear factor-κB during germinal center B-cell development: implications for lymphomagenesis. Curr Opin Hematol (2015) 0.76
Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes. Immunol Res (2015) 0.76
Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia. J Clin Oncol (2017) 0.75
Identification of cell-type-specific mutations in nodal T-cell lymphomas. Blood Cancer J (2017) 0.75
Prognostic signature and clonality pattern of recurrently mutated genes in inactive chronic lymphocytic leukemia. Blood Cancer J (2015) 0.75
Interferon regulatory factor 4 attenuates Notch signaling to suppress the development of chronic lymphocytic leukemia. Oncotarget (2016) 0.75
BRAF(V600E) induces ABCB1/P-glycoprotein expression and drug resistance in B-cells via AP-1 activation. Leuk Res (2015) 0.75
Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia. J Hematol Oncol (2017) 0.75
Chronic lymphocytic leukaemia. Nat Rev Dis Prim (2017) 0.75
A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma. Genome Med (2016) 0.75
Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Blood (2016) 0.75
Tracing the roots of cancer evolution. Cancer Discov (2014) 0.75
Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics. Leuk Lymphoma (2015) 0.75
Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors. Nat Cell Biol (2017) 0.75
Clonal evolution in leukemia. Nat Med (2017) 0.75